- US12595592utility2026Comprehensive Monoclonal Antibody Generation0 cites
- US12473360utility2025Multi-specific Antibody Constructs0 cites
- US12427347utility2025Conditionally Active Anti-epcam Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof0 cites
- US12187801utility2025Chimeric Antigen Receptors Against AXL or ROR2 and Methods of Use Thereof0 cites
- US12110611utility2024Conditionally Active Biological Proteins0 cites
- US11897959utility2024Anti-axl Antibodies, Antibody Fragments and Their Immunoconjugates and Uses Thereof0 cites
- US11879011utility2024Anti-ror2 Antibodies, Antibody Fragments, Their Immunoconjucates and Uses Thereof0 cites
- US11859007utility2024Humanized Anti-cd73 Antibodies0 cites
- US11851499utility2023Conditionally Active Anti-epcam Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof0 cites
- US11834472utility2023Anti-il-22 Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof0 cites
- US11773509utility2023Conditionally Active Polypeptides and Methods of Generating Them0 cites
- US11718844utility2023Mirac Proteins0 cites
- US11639365utility2023Methods of Protein Evolution0 cites
- US11584927utility2023Conditionally Active Chimeric Antigen Receptors for Modified T-cells0 cites
- US11542332utility2023Anti-ctla4 Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof0 cites